WHWK · Whitehawk Therapeutics
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Market Cap
180.6M
52 Wk Range
$1.97 - $5.50
Previous Close
$3.06
Open
$3.06
Volume
261,759
Day Range
$2.94 - $3.10
Enterprise Value
11.41M
Cash
169.7M
Avg Qtr Burn
-19.67M
Insider Ownership
12.33%
Institutional Own.
82.28%
Qtr Updated
Sep 30th 2026
